Alkermes (ALKS) Long-Term Deferred Tax (2011 - 2026)
Alkermes (ALKS) reported Long-Term Deferred Tax of $134.8 million for Q1 2026, down 11.4% year-over-year from $152.1 million in Q1 2025, and up 7.14% quarter-over-quarter from $125.8 million in Q4 2025.
Alkermes (ALKS) Long-Term Deferred Tax (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 15 years of Long-Term Deferred Tax data on file, last reported at $134.8 million in Q1 2026.
- Long-Term Deferred Tax for Q1 2026 came in at $134.8 million, down 11.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $134.8 million (down 11.4% YoY), and the FY2025 annual result was $125.8 million, down 18.74% from the prior year.
- Long-Term Deferred Tax climbed to $134.8 million in Q1 2026 per ALKS's latest filing, from $125.8 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $195.9 million in Q4 2023 and troughed at $112.5 million in Q1 2022.
- A 5-year average of $147.9 million and a median of $152.1 million in 2025 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2023 and 2024: Long-Term Deferred Tax jumped 70.97% in 2023, then slipped 20.96% in 2024.
- A 5-year view of Long-Term Deferred Tax shows it stood at $114.6 million in 2022, then jumped by 70.97% to $195.9 million in 2023, then decreased by 20.96% to $154.8 million in 2024, then slipped by 18.74% to $125.8 million in 2025, then increased by 7.14% to $134.8 million in 2026.
- Business Quant data shows ALKS's Long-Term Deferred Tax at $134.8 million in Q1 2026, $125.8 million in Q4 2025, and $130.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134.80 Mn |
| Dec 31, 2025 | 125.82 Mn |
| Sep 30, 2025 | 130.34 Mn |
| Jun 30, 2025 | 155.53 Mn |
| Mar 31, 2025 | 152.14 Mn |
| Dec 31, 2024 | 154.84 Mn |
| Sep 30, 2024 | 159.96 Mn |
| Jun 30, 2024 | 167.38 Mn |
| Mar 31, 2024 | 182.54 Mn |
| Dec 31, 2023 | 195.89 Mn |
| Sep 30, 2023 | 162.18 Mn |
| Jun 30, 2023 | 153.15 Mn |
| Mar 31, 2023 | 151.23 Mn |
| Dec 31, 2022 | 114.57 Mn |
| Sep 30, 2022 | 137.15 Mn |
| Jun 30, 2022 | 123.70 Mn |
| Mar 31, 2022 | 112.52 Mn |
| Dec 31, 2021 | 81.83 Mn |
| Sep 30, 2021 | 84.50 Mn |
| Jun 30, 2021 | 75.64 Mn |